Skip to search formSkip to main contentSkip to account menu

Bone Density Conservation Agents

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat… 
National Institutes of Health

Related topics

Related topics

45 relations

Narrower (35)

24,25-Dihydroxyvitamin D 325-Hydroxyvitamin D 2AlendronateAlfacalcidol
Bone RegenerationFractureIn BloodOsteoporosis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis.
Osteoporosis, a bone disease resulting in the loss of bone density and microstructure quality, is often associated with fragility… 
2015
2015
Research Hotspots Analysis of Osteoporosis by PubMed
Objective: To understand the research hotspots of osteoporosis by PubMed. Methods: With MS Excel, SPSS, Cytoscape software, we… 
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
  • M. Shiraki
  • Nihon rinsho. Japanese journal of clinical…
  • 2007
  • Corpus ID: 397937
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Minodronic acid].
  • S. Takata
  • Nihon rinsho. Japanese journal of clinical…
  • 2007
  • Corpus ID: 36022025
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Zoledronate].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: ED-71].
  • H. Hagino
  • Nihon rinsho. Japanese journal of clinical…
  • 2007
  • Corpus ID: 9431436
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Ibandronate].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)